Reuters
@Reuters·4.2M subscribers·86.9K videos
AstraZeneca shares drop after vote against breast cancer drug
Posted
May 1, 2026
Views
572
Likes
11
Engagement
1.92%
May 1, 2026
572
11
1.92%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
0:46Now PlayingAstraZeneca shares fell 1.9% after a US FDA panel voted against recommending its experimental breast cancer drug, citing study design concerns.
#News #Reuters #Newsfeed #astrazeneca #health #breastcancer #usa #unitedstates #fda #business #businessnews
Read the story here
👉 Subscribe
Keep up with the latest news from around the world
Follow Reuters on Facebook
Follow Reuters on X
Follow Reuters on Instagram
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
